Increased focus on telehealth marketing by the FDA.
GLP-1 drugs are gaining popularity among prescribers.
Potential implications for companies involved in telehealth.
Strategic angle: The FDA is scrutinizing telehealth marketing practices for GLP-1 drugs, raising questions about prescribing trends.
Increased focus on telehealth marketing by the FDA.
GLP-1 drugs are gaining popularity among prescribers.
Potential implications for companies involved in telehealth.